JLM-BioCity Partner Betalin

Betalin Therapeutics
CEO: Shay Herchcovici
Year Established: 2015

Betalin Therapeutics is developing an innovative and breakthrough therapy for diabetes treatment. This game changing technology aims to replace insulin therapy for millions of patients worldwide.

Betalin Therapeutics’ proprietary technology is a biological micro-environment for supporting the harvested islets. The combination of the harvested cells and the proprietary micro-environment is called Engineered Micro-Pancreas (EMP).